Clarus Lifesciences III, L.P. → AVROBIO, Inc. TECX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 12.64

2,413,729 shares short · -13.6% vs prior

Other 13D/G Filings on AVROBIO, Inc.

Filed	Form	Filer	Stake	Shares
2025-02-10	SCHEDULE	SPRINGER TIMOTHY A	29.20%	4,226,058	view →
2025-02-07	SCHEDULE	Vida Ventures II, LLC	5.60%	1,028,674	view →
2025-02-07	SCHEDULE	MCGUIRE TERRANCE	6.30%	1,157,977	view →
2019-08-06	SC	Clarus Lifesciences III, L.P.	—	—	view →

Other Filings by Clarus Lifesciences III, L.P.

Filed	Form	Issuer	Stake	Shares
2020-07-09	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2019-08-06	SC	AVROBIO, Inc. TECX	—	—	view →
2019-01-11	SC	Forty Seven, Inc.	—	—	view →
2019-01-11	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2019-01-11	SC	ESSA Pharma Inc.	—	—	view →
2019-01-11	SC	Gritstone Oncology, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →